Corcept Therapeutics Incorporated (CORT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corcept Therapeutics Incorporated (CORT)

CORT 82.65

-1.1%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (5)	6/23/2004 9:09:04 PM
From: mopgcw	Read Replies (1) of 32

Corcept Therapeutics Rated New `Outperform' at Thomas Weisel 2004-05-25 08:29 (New York) Princeton, New Jersey, May 25 (Bloomberg Data) -- Corcept Therapeutics Inc. (CORT US) was rated new ``outperform'' in new coverage by analyst Donald B. Ellis at Thomas Weisel Partners. The 12-to-18-month price target is $20.00 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next